Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 564,690 | 537,267 | 567,978 | 596,068 | 536,313 |
| Gross Profit | 564,690 | 537,267 | 567,978 | 596,068 | 536,313 |
| Operating Expenses | -170,384 | 267,637 | 641,752 | -16,828 | 384,871 |
| Operating Income | 735,074 | 269,630 | -73,774 | 612,896 | 151,442 |
| Interest Expense | 66,506 | 49,013 | 44,232 | 47,255 | 46,033 |
| Other Income | 137,790 | -26,240 | 113,733 | 151,945 | 16,668 |
| Pre-tax Income | 806,358 | 194,377 | -4,273 | 717,586 | 122,077 |
| Net Income Continuous | 806,358 | 194,377 | -4,273 | 717,586 | 122,077 |
| Minority Interests | 262,371 | 92,373 | -9,051 | 223,246 | 49,963 |
| Net Income | $543,987 | $102,004 | $4,778 | $494,340 | $72,114 |
| EPS Basic Total Ops | 1.22 | 0.23 | 0.01 | 1.11 | 0.16 |
| EPS Basic Continuous Ops | 1.80 | 0.43 | -0.01 | 1.60 | 0.27 |
| EPS Diluted Total Ops | 1.21 | 0.23 | 0.01 | 1.11 | 0.16 |
| EPS Diluted Continuous Ops | 1.36 | 0.33 | -0.01 | 1.20 | 0.20 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.96 | 0.98 | 1.15 | 0.79 |
| EBITDA(a) | $740,422 | $274,189 | $-69,425 | $617,737 | $156,453 |